Trials / Completed
CompletedNCT04366752
Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The understanding of haemostasis and inflammation cross-talk has gained considerable knowledge during the past decade in the field of arterial and venous thrombosis. Complex and delicately balanced interaction between coagulation and inflammation involve all cellular and humoral components. Elements of the coagulation system such as activated thrombin, fibrinogen or factor Xa may increase inflammation by promoting the production of pro-inflammatory cytokines, chemokines, growth factors and adhesion molecules that lead to a procoagulant state amplifying the pathological process. Recent evidence supports inflammation as a common pathogenic contributor to both arterial and venous thrombosis, giving rise to the concept of inflammation-induced thrombosis. Patients with infection of COVID-19 and severe pneumoniae seem to have higher risk of thromboembolism. Very few data are available regarding the biological disorders of coagulation in these patients. Th purpose of this project is to analyze hemostasis and coagulation of patients with infection of COVID-19 and severe pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | venous ultrasound | Venous ultrasound will be performed on patients once a week, every week from the day of admission in ICU until the day of patient discharge |
| OTHER | blood sample | blood sample for coagulation and hemostasis analysis will be withdrawn from artery catheter from the day of admission in ICU until the day of patient discharge |
Timeline
- Start date
- 2020-04-22
- Primary completion
- 2020-08-22
- Completion
- 2020-09-22
- First posted
- 2020-04-29
- Last updated
- 2023-03-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04366752. Inclusion in this directory is not an endorsement.